कार्बनिक उत्पत्ति की नपुंसकता — शारीरिक कारण से उत्पन्न स्तंभन दोष (ED) — को संतोषजनक यौन प्रदर्शन के लिए पर्याप्त शिश्न स्तंभन प्राप्त करने और/या बनाए रखने में निरंतर या आवर्ती असमर्थता के रूप में परिभाषित किया जाता है। प्रथम-पंक्ति प्रबंधन एक संरचित, साक्ष्य-आधारित प्रोटोकॉल का पालन करता है जो व्यवहारिक और औषधीय हस्तक्षेपों को संयुक्त करता है।
DOI: 10.1016/j.juro.2018.05.004
Erectile dysfunction (ED) can be conceptualized as an impairment in the arousal phase of sexual response and is defined as the consistent or recurrent inability to attain and/or maintain penile erection sufficient for sexual satisfaction, including satisfactory sexual performance.
Clinicians should counsel men with ED who have comorbidities known to negatively affect erectile function that lifestyle modifications, including changes in diet and increased physical activity, improve overall health and may improve erectile function.
Men with ED should be informed regarding the treatment option of an FDA-approved oral phosphodiesterase type 5 inhibitor (PDE5i), including discussion of benefits and risks/burdens, unless contraindicated.
For men who are prescribed PDE5i, the dose should be titrated to provide optimal efficacy.
View source ↗